Igen (US) gets further patent protection for Origen:
This article was originally published in Clinica
Igen (US) has been granted Canadian and European patent protection for its electrochemiluminescence-based Origen technology. Two further US patents have also been granted, bringing to 12 the total number of US patents covering the technology.
You may also be interested in...
To be more transparent and allow more public discourse, the HHS now requires all its agencies to publish documents it uses to rationalize proposed rules and demonstration projects.
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from India's Glenmark.
Second read-out maintains 94% level of efficacy, with a very early signal that it could outperform Pfizer’s rival mRNA candidate in preventing severe cases.